The study titled "The Performance of Top Coronavirus Vaccine Stocks during COVID-19 Pandemic: A Multifractal Analysis" by Assoc. Prof. Onur ÖZDEMİR, an academician of the Faculty of Economics, Administrative and Social Sciences, Department of International Trade and Finance (English) was published in Sosyoekonomi. The main concern in the study is to document whether the presence of herd investing and the level of market efficiency changed between pre-vaccination (i.e., 9 December 2019 - 8 December 2020) and post-vaccination (i.e., 9 December 2020 - 6 January 2022). The results indicate that the post-vaccination period is more prone to herd investing in BioNTech and Moderna stocks. Considering the impacts of this far-reaching outbreak, the highest MLM (inefficiency) index value is also attributed to BioNTech before and after the COVID-19 vaccination process.
You can find the study
here.
